Abstract
Rosacea is a frequent chronic dermatosis on the central region of the face. It is underdiagnosed and can have a significant impact on the sufferers’ quality of life. It is more often seen in an intermediate age range and is prevalent in women, although it can occur during childhood and severe cases are seen in men. Rosacea has a multiple etiopathogenic basis and different clinical types. The vascular and the inflammatory processes in a deconstructing dermal framework account for the most often found clinical types: erythematous telangiectatic, papulopustular, and phymatous. Ocular rosacea should be properly investigated. The differential diagnosis is made mainly with other facial dermatoses, such as acne, seborrheic dermatitis, atopic dermatitis, periorificial dermatitis, contact dermatitis, dermatomyositis, and lupus erythematosus. Treatment includes refraining from exposition to triggering factors and the use of topical and systemic medication. Topical metronidazole, ivermectin, azelaic acid, and brimonidine, as well as systemic doxycycline, carvedilol, and isotretinoin, are drugs of choice, besides different types of laser.
References
Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol. 2010;24(5):565–71.
Lomholt G. Prevalence of skin diseases in a population; a Census Study from the Faroe Islands. Dan Med Bull. 1964;11:1–7.
Schaefer I, Rustenbach SJ, Zimmer L, Augustin M. Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology. 2008;217(2):169–72.
Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Schafer I. Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol. 2011;165(4):865–73.
McAleer MA, Fitzpatrick P, Powell FC. Papulopustular rosacea: prevalence and relationship to photodamage. J Am Acad Dermatol. 2010;63(1):33–9.
Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol. 1989;69(5):419–23.
Bamford JT, Gessert CE, Renier CM, Jackson MM, Laabs SB, Dahl MV, et al. Childhood stye and adult rosacea. J Am Acad Dermatol. 2006;55(6):951–5.
Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G. Healthcare utilization and costs of patients with rosacea in an insured population. J Drugs Dermatol. 2008;7(1):41–9.
Doe PT, Asiedu A, Acheampong JW, Rowland Payne CM. Skin diseases in Ghana and the UK. Int J Dermatol. 2001;40(5):323–6.
Kyriakis KP, Palamaras I, Terzoudi S, Emmanuelides S, Michailides C, Pagana G. Epidemiologic aspects of rosacea. J Am Acad Dermatol. 2005;53(5):918–9.
Khaled A, Hammami H, Zeglaoui F, Tounsi J, Zermani R, Kamoun MR, et al. Rosacea: 244 Tunisian cases. Tunis Med. 2010;88(8):597–601.
Gutierrez EL, Galarza C, Ramos W, Mendoza M, Smith ME, Ortega-Loayza AG. Influence of climatic factors on the medical attentions of dermatologic diseases in a hospital of Lima. Peru An Bras Dermatol. 2010;85(4):461–8.
Abram K, Silm H, Oona M. Prevalence of rosacea in an Estonian working population using a standard classification. Acta Derm Venereol. 2010;90(3):269–73.
Lazaridou E, Fotiadou C, Ziakas NG, Giannopoulou C, Apalla Z, Ioannides D. Clinical and laboratory study of ocular rosacea in northern Greece. J Eur Acad Dermatol Venereol. 2011;25(12):1428–31.
Spoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology of rosacea in the U.K. Br J Dermatol. 2012;167(3):598–605.
Culp B, Scheinfeld N. Rosacea: a review. P T. 2009;34(1):38–45.
Powell FC. Clinical practice. Rosacea. N Engl J Med. 2005;352(8):793–803.
Kroshinsky D, Glick SA. Pediatric rosacea. Dermatol Ther. 2006;19(4):196–201.
Lacz NL, Schwartz RA. Rosacea in the pediatric population. Cutis. 2004;74(2):99–103.
Bertolini W, Duquia RP, de Oliveira OL, de Campos GF, Bonamigo RR. Could a simple microbiological culture and an antibiogram guide the treatment of our patients with papulopustular rosacea (PPR)? J Am Acad Dermatol. 2015;73(3):e113–4.
Bonamigo RR, Leite CS, Wagner M, Bakos L. Rosacea and Helicobacter pylori: interference of systemic antibiotic in the study of possible association. J Eur Acad Dermatol Venereol. 2000;14(5):424–5.
Whitfeld M, Gunasingam N, Leow LJ, Shirato K, Preda V. Staphylococcus epidermidis: a possible role in the pustules of rosacea. J Am Acad Dermatol. 2011;64(1):49–52.
Gravina A, Federico A, Ruocco E, Lo Schiavo A, Masarone M, Tuccillo C, et al. Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. United Eur Gastroenterol J. 2015;3(1):17–24.
Aldrich N, Gerstenblith M, Fu P, Tuttle MS, Varma P, Gotow E, et al. Genetic vs environmental factors that correlate with rosacea: a cohort-based survey of twins. JAMA Dermatol. 2015;151(11):1213–9.
Tan SG, Cunliffe WJ. Rosacea and migraine. Br Med J. 1976;1(6000):21.
Gupta MA, Gupta AK, Chen SJ, Johnson AM. Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey – Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002. Br J Dermatol. 2005;153(6):1176–81.
Curnier A, Choudhary S. Rhinophyma: dispelling the myths. Plast Reconstr Surg. 2004;114(2):351–4.
Sobye P. Aetiology and pathogenesis of rosacea. Acta Derm Venereol. 1950;30(2):137–58.
Plewig G, Kligman AM, editors. Acne and rosacea. 3rd ed. Berlin: Springer; 2000. 744 p
Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004;50(6):907–12.
Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):2–11.
Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584–7.
Steinhoff M, Bergstresser PR. Pathophysiology of rosacea: introduction. J Investig Dermatol Symp Proc. 2011;15(1):1.
Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72(5):749–58. quiz 59–60
Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13(8):975–80.
Schauber J, Gallo RL. Expanding the roles of antimicrobial peptides in skin: alarming and arming keratinocytes. J Invest Dermatol. 2007;127(3):510–2.
Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest. 2003;111(11):1665–72.
Yamasaki K, Kanada K, Macleod DT, Borkowski AW, Morizane S, Nakatsuji T, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol. 2011;131(3):688–97.
Zhao YE, Wu LP, Peng Y, Cheng H. Retrospective analysis of the association between Demodex infestation and rosacea. Arch Dermatol. 2010;146(8):896–902.
Jarmuda S, O’Reilly N, Zaba R, Jakubowicz O, Szkaradkiewicz A, Kavanagh K. Potential role of Demodex mites and bacteria in the induction of rosacea. J Med Microbiol. 2012;61(Pt 11):1504–10.
Lacey N, Delaney S, Kavanagh K, Powell FC. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol. 2007;157(3):474–81.
Jang YH, Sim JH, Kang HY, Kim YC, Lee ES. Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea. J Eur Acad Dermatol Venereol. 2011;25(5):544–8.
Bonamigo RR, Bakos L, Edelweiss M, Cartell A. Could matrix metalloproteinase-9 be a link between Demodex folliculorum and rosacea? J Eur Acad Dermatol Venereol. 2005;19(5):646–7.
Muto Y, Wang Z, Vanderberghe M, Two A, Gallo RL, Di Nardo A. Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea. J Invest Dermatol. 2014;134(11):2728–36.
Schwab VD, Sulk M, Seeliger S, Nowak P, Aubert J, Mess C, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):53–62.
Schauber J, Gallo RL. The vitamin D pathway: a new target for control of the skin’s immune response? Exp Dermatol. 2008;17(8):633–9.
Ekiz O, Balta I, Sen BB, Dikilitas MC, Ozuguz P, Rifaioglu EN. Vitamin D status in patients with rosacea. Cutan Ocul Toxicol. 2014;33(1):60–2.
Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327–41. quiz 42–4
Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. J Am Acad Dermatol. 1993;28(3):443–8.
Lazaridou E, Apalla Z, Sotiraki S, Ziakas NG, Fotiadou C, Ioannides D. Clinical and laboratory study of rosacea in northern Greece. J Eur Acad Dermatol Venereol. 2010;24(4):410–4.
Buechner SA. Rosacea: an update. Dermatology. 2005;210(2):100–8.
Bevins CL, Liu FT. Rosacea: skin innate immunity gone awry? Nat Med. 2007;13(8):904–6.
Ferrer L, Ravera I, Silbermayr K. Immunology and pathogenesis of canine demodicosis. Vet Dermatol. 2014;25(5):427–e65.
Hsu CK, Hsu MM, Lee JY. Demodicosis: a clinicopathological study. J Am Acad Dermatol. 2009;60(3):453–62.
O’Reilly N, Bergin D, Reeves EP, McElvaney NG, Kavanagh K. Demodex-associated bacterial proteins induce neutrophil activation. Br J Dermatol. 2012;166(4):753–60.
Murillo N, Aubert J, Raoult D. Microbiota of Demodex mites from rosacea patients and controls. Microb Pathog. 2014;71–72:37–40.
Lazaridou E, Giannopoulou C, Fotiadou C, Vakirlis E, Trigoni A, Ioannides D. The potential role of microorganisms in the development of rosacea. J Dtsch Dermatol Ges. 2011;9(1):21–5.
Cribier B. Rosacea under the microscope: characteristic histological findings. J Eur Acad Dermatol Venereol. 2013;27(11):1336–43.
Zouboulis CC, Katsambas AD, Kligman AM. Pathogenesis and treatment of acne and rosacea. Heidelberg: Springer; 2014. 768 p
Jones ME, Karlowsky JA, Draghi DC, Thornsberry C, Sahm DF, Bradley JS. Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients. Eur J Clin Microbiol Infect Dis. 2004;23(6):445–55.
Gerber PA, Buhren BA, Steinhoff M, Homey B. Rosacea: the cytokine and chemokine network. J Investig Dermatol Symp Proc. 2011;15(1):40–7.
Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci. 2009;55(2):77–81.
Yamasaki K, Gallo RL. Rosacea as a disease of cathelicidins and skin innate immunity. J Investig Dermatol Symp Proc. 2011;15(1):12–5.
Morizane S, Yamasaki K, Kabigting FD, Gallo RL. Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid. J Invest Dermatol. 2010;130(5):1297–306.
Aubdool AA, Brain SD. Neurovascular aspects of skin neurogenic inflammation. J Investig Dermatol Symp Proc. 2011;15(1):33–9.
Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev. 2007;87(1):165–217.
Guzman-Sanchez DA, Ishiuji Y, Patel T, Fountain J, Chan YH, Yosipovitch G. Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea. J Am Acad Dermatol. 2007;57(5):800–5.
Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013;69(6 Suppl 1):S15–26.
Ni Raghallaigh S, Bender K, Lacey N, Brennan L, Powell FC. The fatty acid profile of the skin surface lipid layer in papulopustular rosacea. Br J Dermatol. 2012;166(2):279–87.
Gomaa AH, Yaar M, Eyada MM, Bhawan J. Lymphangiogenesis and angiogenesis in non-phymatous rosacea. J Cutan Pathol. 2007;34(10):748–53.
Huggenberger R, Detmar M. The cutaneous vascular system in chronic skin inflammation. J Investig Dermatol Symp Proc. 2011;15(1):24–32.
Fowler J, Jarratt M, Moore A, Meadows K, Pollack A, Steinhoff M, et al. Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. Br J Dermatol. 2012;166(3):633–41.
Seeliger S, Buddenkotte J, Schmidt-Choudhury A, Rosignoli C, Shpacovitch V, von Arnim U, et al. Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo. Am J Pathol. 2010;177(5):2563–75.
Powell FC. The histopathology of rosacea: ‘where’s the beef?’. Dermatology. 2004;209(3):173–4.
Burns T, Breathnach S, Cox N. Griffiths C. Rook’s textbook of dermatology. 2010 ed. UK: Wiley-Blackwell; 2010, p. 43.1–.7.
Tan J, Blume-Peytavi U, Ortonne JP, Wilhelm K, Marticou L, Baltas E, et al. An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol. 2013;169(3):555–62.
Bonamigo RR, Bakos L, Cartell A, Edelweiss MI. Fatores associados à rosácea em amostras populacionais do Sul do Brasil: análise de estudos casos-controles. An Bras Dermatol. 2008;83:419–24.
Cribier B. Pathophysiology of rosacea: redness, telangiectasia, and rosacea. Ann Dermatol Venereol. 2011;138(Suppl 3):S184–91.
Aloi F, Tomasini C, Soro E, Pippione M. The clinicopathologic spectrum of rhinophyma. J Am Acad Dermatol. 2000;42(3):468–72.
Aksoy B, Altaykan-Hapa A, Egemen D, Karagoz F, Atakan N. The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol. 2010;163(4):719–25.
Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004;51(4):499–512. quiz 3–4
Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol. 2015;72(5):761–70. quiz 71–2
Elewski BE, Draelos Z, Dreno B, Jansen T, Layton A, Picardo M. Rosacea – global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol. 2011;25(2):188–200.
Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield L, et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care. Cutis. 2013;92(5):234–40.
van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L. Interventions for rosacea. Cochrane Database Syst Rev. 2015;4:CD003262.
Stinco G, Bragadin G, Trotter D, Pillon B, Patrone P. Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne. J Eur Acad Dermatol Venereol. 2007;21(3):320–5.
Coda AB, Hata T, Miller J, Audish D, Kotol P, Two A, et al. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol. 2013;69(4):570–7.
Wise RD. Submicrobial doxycycline and rosacea. Compr Ther. 2007;33(2):78–81.
Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn VB, Gallo RL.Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea.Nat Med. 2007 Aug;13(8):975–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Glossary
- Cathelicidin
-
Antimicrobial peptides found in the mammalian tissue induced by injury or inflammation. They belong to the immune system and work as activators and controllers of immune reactions.
- Flushing
-
The most common symptom of rosacea, characterized by a transient facial blush or redness. The skin can be lightly rose as if blushed, or it may seem slightly sunburned. Sufferers may refer to itching or pricking during rosacea flares.
- GRADE (Grading of Recommendations Assessment, Development, and Evaluation)
-
System developed by a group of collaborative researchers aiming at the creation of a universal, transparent, and sensitive system to grade the quality of scientific evidence and recommendation power. The GRADE system classifies evidence quality (reliability of the used information) at four levels: high (powerful reliability of the real effect is near the assessed one), moderate (moderate reliability of the assessed effect), low (limited effect reliability), and very low (very limited reliability of the effect assessment). There is a significant uncertainty degree in the findings. Evidence from randomized clinical trials begins with high evidence level; evidence from observational studies begins with low evidence level.
- Kallikrein
-
A polypeptide of proteolytic reaction which acts upon protein substrates of varied nature. Kallikrein has a vasodilating direct action, but also an indirect one because of its proteolytic feature.
- Metalloproteinases
-
An important group of zinc-dependent proteolytic enzymes (endopeptidases) that account for the degradation of the extracellular matrix and the basal membranes. The metalloproteinases degrade the matrix macromolecules including interstitial collagen, fibronectin, lamina, and proteoglycan, among others. The expression of many metalloproteinases is increased in the skin of rosacea patients.
- Photodamage
-
Represented by clinical changes resulting from acute or chronic events determined by biochemical and molecular processes caused by ultraviolet radiation exposure.
- Phyma
-
A rosacea phase determined by sebaceous gland hyperplasia, initially showing erythema, edema, and follicular orifice dilation, followed by the development of fibrous tissue. This process can affect the nose (rhinophyma), the mentum/chin (gnatophyma), the forehead (metophyma), the ears (otophyma), and the eyelids (blepharophyma).
- Transcriptome
-
The transcriptome corresponds to the genetic code fraction (DNA) transcribed by the RNA polymerase into the RNA molecules, that is, an organ, tissue, or cell lineage’s total set of transcripts (RNA messengers, ribosomal RNAs, transporter RNAs, and microRNAs).
Rights and permissions
Copyright information
© 2018 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bonamigo, R.R., Bertolini, W., Dornelles, S.I.T. (2018). Rosacea. In: Bonamigo, R., Dornelles, S. (eds) Dermatology in Public Health Environments. Springer, Cham. https://doi.org/10.1007/978-3-319-33919-1_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-33919-1_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33917-7
Online ISBN: 978-3-319-33919-1
eBook Packages: MedicineMedicine (R0)